The Market Reports

Index

1 Market Overview
1.1 Product Overview and Scope of Viral Vector and Plasmid DNA
1.2 Classification of Viral Vector and Plasmid DNA by Type
1.2.1 Overview: Global Viral Vector and Plasmid DNA Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Viral Vector and Plasmid DNA Revenue Market Share by Type in 2021
1.2.3 Plasmid DNA
1.2.4 Viral Vector
1.3 Global Viral Vector and Plasmid DNA Market by Application
1.3.1 Overview: Global Viral Vector and Plasmid DNA Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Cancer
1.3.3 Virus Infection
1.3.4 Hereditary Disease
1.4 Global Viral Vector and Plasmid DNA Market Size & Forecast
1.5 Global Viral Vector and Plasmid DNA Market Size and Forecast by Region
1.5.1 Global Viral Vector and Plasmid DNA Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Viral Vector and Plasmid DNA Market Size by Region, (2017-2022)
1.5.3 North America Viral Vector and Plasmid DNA Market Size and Prospect (2017-2028)
1.5.4 Europe Viral Vector and Plasmid DNA Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Viral Vector and Plasmid DNA Market Size and Prospect (2017-2028)
1.5.6 South America Viral Vector and Plasmid DNA Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Viral Vector and Plasmid DNA Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Viral Vector and Plasmid DNA Market Drivers
1.6.2 Viral Vector and Plasmid DNA Market Restraints
1.6.3 Viral Vector and Plasmid DNA Trends Analysis
2 Company Profiles
2.1 Brammer Bio
2.1.1 Brammer Bio Details
2.1.2 Brammer Bio Major Business
2.1.3 Brammer Bio Viral Vector and Plasmid DNA Product and Solutions
2.1.4 Brammer Bio Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Brammer Bio Recent Developments and Future Plans
2.2 Oxford BioMedica
2.2.1 Oxford BioMedica Details
2.2.2 Oxford BioMedica Major Business
2.2.3 Oxford BioMedica Viral Vector and Plasmid DNA Product and Solutions
2.2.4 Oxford BioMedica Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Oxford BioMedica Recent Developments and Future Plans
2.3 Cobra Biologics
2.3.1 Cobra Biologics Details
2.3.2 Cobra Biologics Major Business
2.3.3 Cobra Biologics Viral Vector and Plasmid DNA Product and Solutions
2.3.4 Cobra Biologics Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Cobra Biologics Recent Developments and Future Plans
2.4 FinVector
2.4.1 FinVector Details
2.4.2 FinVector Major Business
2.4.3 FinVector Viral Vector and Plasmid DNA Product and Solutions
2.4.4 FinVector Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 FinVector Recent Developments and Future Plans
2.5 Lonza
2.5.1 Lonza Details
2.5.2 Lonza Major Business
2.5.3 Lonza Viral Vector and Plasmid DNA Product and Solutions
2.5.4 Lonza Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Lonza Recent Developments and Future Plans
2.6 BioReliance
2.6.1 BioReliance Details
2.6.2 BioReliance Major Business
2.6.3 BioReliance Viral Vector and Plasmid DNA Product and Solutions
2.6.4 BioReliance Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 BioReliance Recent Developments and Future Plans
2.7 MolMed
2.7.1 MolMed Details
2.7.2 MolMed Major Business
2.7.3 MolMed Viral Vector and Plasmid DNA Product and Solutions
2.7.4 MolMed Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 MolMed Recent Developments and Future Plans
2.8 FUJIFILM Diosynth Biotechnologies
2.8.1 FUJIFILM Diosynth Biotechnologies Details
2.8.2 FUJIFILM Diosynth Biotechnologies Major Business
2.8.3 FUJIFILM Diosynth Biotechnologies Viral Vector and Plasmid DNA Product and Solutions
2.8.4 FUJIFILM Diosynth Biotechnologies Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 FUJIFILM Diosynth Biotechnologies Recent Developments and Future Plans
2.9 UniQure
2.9.1 UniQure Details
2.9.2 UniQure Major Business
2.9.3 UniQure Viral Vector and Plasmid DNA Product and Solutions
2.9.4 UniQure Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 UniQure Recent Developments and Future Plans
2.10 Aldevron
2.10.1 Aldevron Details
2.10.2 Aldevron Major Business
2.10.3 Aldevron Viral Vector and Plasmid DNA Product and Solutions
2.10.4 Aldevron Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Aldevron Recent Developments and Future Plans
2.11 Richter-Helm
2.11.1 Richter-Helm Details
2.11.2 Richter-Helm Major Business
2.11.3 Richter-Helm Viral Vector and Plasmid DNA Product and Solutions
2.11.4 Richter-Helm Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Richter-Helm Recent Developments and Future Plans
2.12 Eurogentec
2.12.1 Eurogentec Details
2.12.2 Eurogentec Major Business
2.12.3 Eurogentec Viral Vector and Plasmid DNA Product and Solutions
2.12.4 Eurogentec Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Eurogentec Recent Developments and Future Plans
2.13 OBiO Technology
2.13.1 OBiO Technology Details
2.13.2 OBiO Technology Major Business
2.13.3 OBiO Technology Viral Vector and Plasmid DNA Product and Solutions
2.13.4 OBiO Technology Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 OBiO Technology Recent Developments and Future Plans
2.14 Yposkesi
2.14.1 Yposkesi Details
2.14.2 Yposkesi Major Business
2.14.3 Yposkesi Viral Vector and Plasmid DNA Product and Solutions
2.14.4 Yposkesi Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14.5 Yposkesi Recent Developments and Future Plans
2.15 Cell and Gene Therapy Catapult
2.15.1 Cell and Gene Therapy Catapult Details
2.15.2 Cell and Gene Therapy Catapult Major Business
2.15.3 Cell and Gene Therapy Catapult Viral Vector and Plasmid DNA Product and Solutions
2.15.4 Cell and Gene Therapy Catapult Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15.5 Cell and Gene Therapy Catapult Recent Developments and Future Plans
2.16 MassBiologics
2.16.1 MassBiologics Details
2.16.2 MassBiologics Major Business
2.16.3 MassBiologics Viral Vector and Plasmid DNA Product and Solutions
2.16.4 MassBiologics Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16.5 MassBiologics Recent Developments and Future Plans
2.17 Biovian
2.17.1 Biovian Details
2.17.2 Biovian Major Business
2.17.3 Biovian Viral Vector and Plasmid DNA Product and Solutions
2.17.4 Biovian Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17.5 Biovian Recent Developments and Future Plans
2.18 VGXI
2.18.1 VGXI Details
2.18.2 VGXI Major Business
2.18.3 VGXI Viral Vector and Plasmid DNA Product and Solutions
2.18.4 VGXI Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.18.5 VGXI Recent Developments and Future Plans
2.19 Gene Synthesis
2.19.1 Gene Synthesis Details
2.19.2 Gene Synthesis Major Business
2.19.3 Gene Synthesis Viral Vector and Plasmid DNA Product and Solutions
2.19.4 Gene Synthesis Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.19.5 Gene Synthesis Recent Developments and Future Plans
2.20 PlasmidFactory
2.20.1 PlasmidFactory Details
2.20.2 PlasmidFactory Major Business
2.20.3 PlasmidFactory Viral Vector and Plasmid DNA Product and Solutions
2.20.4 PlasmidFactory Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.20.5 PlasmidFactory Recent Developments and Future Plans
2.21 Jikai Gene
2.21.1 Jikai Gene Details
2.21.2 Jikai Gene Major Business
2.21.3 Jikai Gene Viral Vector and Plasmid DNA Product and Solutions
2.21.4 Jikai Gene Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.21.5 Jikai Gene Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Viral Vector and Plasmid DNA Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Viral Vector and Plasmid DNA Players Market Share in 2021
3.2.2 Top 10 Viral Vector and Plasmid DNA Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Viral Vector and Plasmid DNA Players Head Office, Products and Services Provided
3.4 Viral Vector and Plasmid DNA Mergers & Acquisitions
3.5 Viral Vector and Plasmid DNA New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Viral Vector and Plasmid DNA Revenue and Market Share by Type (2017-2022)
4.2 Global Viral Vector and Plasmid DNA Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Viral Vector and Plasmid DNA Revenue Market Share by Application (2017-2022)
5.2 Global Viral Vector and Plasmid DNA Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Viral Vector and Plasmid DNA Revenue by Type (2017-2028)
6.2 North America Viral Vector and Plasmid DNA Revenue by Application (2017-2028)
6.3 North America Viral Vector and Plasmid DNA Market Size by Country
6.3.1 North America Viral Vector and Plasmid DNA Revenue by Country (2017-2028)
6.3.2 United States Viral Vector and Plasmid DNA Market Size and Forecast (2017-2028)
6.3.3 Canada Viral Vector and Plasmid DNA Market Size and Forecast (2017-2028)
6.3.4 Mexico Viral Vector and Plasmid DNA Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Viral Vector and Plasmid DNA Revenue by Type (2017-2028)
7.2 Europe Viral Vector and Plasmid DNA Revenue by Application (2017-2028)
7.3 Europe Viral Vector and Plasmid DNA Market Size by Country
7.3.1 Europe Viral Vector and Plasmid DNA Revenue by Country (2017-2028)
7.3.2 Germany Viral Vector and Plasmid DNA Market Size and Forecast (2017-2028)
7.3.3 France Viral Vector and Plasmid DNA Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Viral Vector and Plasmid DNA Market Size and Forecast (2017-2028)
7.3.5 Russia Viral Vector and Plasmid DNA Market Size and Forecast (2017-2028)
7.3.6 Italy Viral Vector and Plasmid DNA Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Viral Vector and Plasmid DNA Revenue by Type (2017-2028)
8.2 Asia-Pacific Viral Vector and Plasmid DNA Revenue by Application (2017-2028)
8.3 Asia-Pacific Viral Vector and Plasmid DNA Market Size by Region
8.3.1 Asia-Pacific Viral Vector and Plasmid DNA Revenue by Region (2017-2028)
8.3.2 China Viral Vector and Plasmid DNA Market Size and Forecast (2017-2028)
8.3.3 Japan Viral Vector and Plasmid DNA Market Size and Forecast (2017-2028)
8.3.4 South Korea Viral Vector and Plasmid DNA Market Size and Forecast (2017-2028)
8.3.5 India Viral Vector and Plasmid DNA Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Viral Vector and Plasmid DNA Market Size and Forecast (2017-2028)
8.3.7 Australia Viral Vector and Plasmid DNA Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Viral Vector and Plasmid DNA Revenue by Type (2017-2028)
9.2 South America Viral Vector and Plasmid DNA Revenue by Application (2017-2028)
9.3 South America Viral Vector and Plasmid DNA Market Size by Country
9.3.1 South America Viral Vector and Plasmid DNA Revenue by Country (2017-2028)
9.3.2 Brazil Viral Vector and Plasmid DNA Market Size and Forecast (2017-2028)
9.3.3 Argentina Viral Vector and Plasmid DNA Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Viral Vector and Plasmid DNA Revenue by Type (2017-2028)
10.2 Middle East & Africa Viral Vector and Plasmid DNA Revenue by Application (2017-2028)
10.3 Middle East & Africa Viral Vector and Plasmid DNA Market Size by Country
10.3.1 Middle East & Africa Viral Vector and Plasmid DNA Revenue by Country (2017-2028)
10.3.2 Turkey Viral Vector and Plasmid DNA Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Viral Vector and Plasmid DNA Market Size and Forecast (2017-2028)
10.3.4 UAE Viral Vector and Plasmid DNA Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables

List of Tables
Table 1. Global Viral Vector and Plasmid DNA Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Viral Vector and Plasmid DNA Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Viral Vector and Plasmid DNA Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Viral Vector and Plasmid DNA Revenue (USD Million) by Region (2017-2022)
Table 5. Global Viral Vector and Plasmid DNA Revenue Market Share by Region (2023-2028)
Table 6. Brammer Bio Corporate Information, Head Office, and Major Competitors
Table 7. Brammer Bio Major Business
Table 8. Brammer Bio Viral Vector and Plasmid DNA Product and Solutions
Table 9. Brammer Bio Viral Vector and Plasmid DNA Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Oxford BioMedica Corporate Information, Head Office, and Major Competitors
Table 11. Oxford BioMedica Major Business
Table 12. Oxford BioMedica Viral Vector and Plasmid DNA Product and Solutions
Table 13. Oxford BioMedica Viral Vector and Plasmid DNA Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Cobra Biologics Corporate Information, Head Office, and Major Competitors
Table 15. Cobra Biologics Major Business
Table 16. Cobra Biologics Viral Vector and Plasmid DNA Product and Solutions
Table 17. Cobra Biologics Viral Vector and Plasmid DNA Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. FinVector Corporate Information, Head Office, and Major Competitors
Table 19. FinVector Major Business
Table 20. FinVector Viral Vector and Plasmid DNA Product and Solutions
Table 21. FinVector Viral Vector and Plasmid DNA Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Lonza Corporate Information, Head Office, and Major Competitors
Table 23. Lonza Major Business
Table 24. Lonza Viral Vector and Plasmid DNA Product and Solutions
Table 25. Lonza Viral Vector and Plasmid DNA Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. BioReliance Corporate Information, Head Office, and Major Competitors
Table 27. BioReliance Major Business
Table 28. BioReliance Viral Vector and Plasmid DNA Product and Solutions
Table 29. BioReliance Viral Vector and Plasmid DNA Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. MolMed Corporate Information, Head Office, and Major Competitors
Table 31. MolMed Major Business
Table 32. MolMed Viral Vector and Plasmid DNA Product and Solutions
Table 33. MolMed Viral Vector and Plasmid DNA Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. FUJIFILM Diosynth Biotechnologies Corporate Information, Head Office, and Major Competitors
Table 35. FUJIFILM Diosynth Biotechnologies Major Business
Table 36. FUJIFILM Diosynth Biotechnologies Viral Vector and Plasmid DNA Product and Solutions
Table 37. FUJIFILM Diosynth Biotechnologies Viral Vector and Plasmid DNA Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. UniQure Corporate Information, Head Office, and Major Competitors
Table 39. UniQure Major Business
Table 40. UniQure Viral Vector and Plasmid DNA Product and Solutions
Table 41. UniQure Viral Vector and Plasmid DNA Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Aldevron Corporate Information, Head Office, and Major Competitors
Table 43. Aldevron Major Business
Table 44. Aldevron Viral Vector and Plasmid DNA Product and Solutions
Table 45. Aldevron Viral Vector and Plasmid DNA Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Richter-Helm Corporate Information, Head Office, and Major Competitors
Table 47. Richter-Helm Major Business
Table 48. Richter-Helm Viral Vector and Plasmid DNA Product and Solutions
Table 49. Richter-Helm Viral Vector and Plasmid DNA Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Eurogentec Corporate Information, Head Office, and Major Competitors
Table 51. Eurogentec Major Business
Table 52. Eurogentec Viral Vector and Plasmid DNA Product and Solutions
Table 53. Eurogentec Viral Vector and Plasmid DNA Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. OBiO Technology Corporate Information, Head Office, and Major Competitors
Table 55. OBiO Technology Major Business
Table 56. OBiO Technology Viral Vector and Plasmid DNA Product and Solutions
Table 57. OBiO Technology Viral Vector and Plasmid DNA Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. Yposkesi Corporate Information, Head Office, and Major Competitors
Table 59. Yposkesi Major Business
Table 60. Yposkesi Viral Vector and Plasmid DNA Product and Solutions
Table 61. Yposkesi Viral Vector and Plasmid DNA Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 62. Cell and Gene Therapy Catapult Corporate Information, Head Office, and Major Competitors
Table 63. Cell and Gene Therapy Catapult Major Business
Table 64. Cell and Gene Therapy Catapult Viral Vector and Plasmid DNA Product and Solutions
Table 65. Cell and Gene Therapy Catapult Viral Vector and Plasmid DNA Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 66. MassBiologics Corporate Information, Head Office, and Major Competitors
Table 67. MassBiologics Major Business
Table 68. MassBiologics Viral Vector and Plasmid DNA Product and Solutions
Table 69. MassBiologics Viral Vector and Plasmid DNA Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 70. Biovian Corporate Information, Head Office, and Major Competitors
Table 71. Biovian Major Business
Table 72. Biovian Viral Vector and Plasmid DNA Product and Solutions
Table 73. Biovian Viral Vector and Plasmid DNA Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 74. VGXI Corporate Information, Head Office, and Major Competitors
Table 75. VGXI Major Business
Table 76. VGXI Viral Vector and Plasmid DNA Product and Solutions
Table 77. VGXI Viral Vector and Plasmid DNA Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 78. Gene Synthesis Corporate Information, Head Office, and Major Competitors
Table 79. Gene Synthesis Major Business
Table 80. Gene Synthesis Viral Vector and Plasmid DNA Product and Solutions
Table 81. Gene Synthesis Viral Vector and Plasmid DNA Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 82. PlasmidFactory Corporate Information, Head Office, and Major Competitors
Table 83. PlasmidFactory Major Business
Table 84. PlasmidFactory Viral Vector and Plasmid DNA Product and Solutions
Table 85. PlasmidFactory Viral Vector and Plasmid DNA Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 86. Jikai Gene Corporate Information, Head Office, and Major Competitors
Table 87. Jikai Gene Major Business
Table 88. Jikai Gene Viral Vector and Plasmid DNA Product and Solutions
Table 89. Jikai Gene Viral Vector and Plasmid DNA Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 90. Global Viral Vector and Plasmid DNA Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 91. Global Viral Vector and Plasmid DNA Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 92. Breakdown of Viral Vector and Plasmid DNA by Company Type (Tier 1, Tier 2 and Tier 3)
Table 93. Viral Vector and Plasmid DNA Players Head Office, Products and Services Provided
Table 94. Viral Vector and Plasmid DNA Mergers & Acquisitions in the Past Five Years
Table 95. Viral Vector and Plasmid DNA New Entrants and Expansion Plans
Table 96. Global Viral Vector and Plasmid DNA Revenue (USD Million) by Type (2017-2022)
Table 97. Global Viral Vector and Plasmid DNA Revenue Share by Type (2017-2022)
Table 98. Global Viral Vector and Plasmid DNA Revenue Forecast by Type (2023-2028)
Table 99. Global Viral Vector and Plasmid DNA Revenue by Application (2017-2022)
Table 100. Global Viral Vector and Plasmid DNA Revenue Forecast by Application (2023-2028)
Table 101. North America Viral Vector and Plasmid DNA Revenue by Type (2017-2022) & (USD Million)
Table 102. North America Viral Vector and Plasmid DNA Revenue by Type (2023-2028) & (USD Million)
Table 103. North America Viral Vector and Plasmid DNA Revenue by Application (2017-2022) & (USD Million)
Table 104. North America Viral Vector and Plasmid DNA Revenue by Application (2023-2028) & (USD Million)
Table 105. North America Viral Vector and Plasmid DNA Revenue by Country (2017-2022) & (USD Million)
Table 106. North America Viral Vector and Plasmid DNA Revenue by Country (2023-2028) & (USD Million)
Table 107. Europe Viral Vector and Plasmid DNA Revenue by Type (2017-2022) & (USD Million)
Table 108. Europe Viral Vector and Plasmid DNA Revenue by Type (2023-2028) & (USD Million)
Table 109. Europe Viral Vector and Plasmid DNA Revenue by Application (2017-2022) & (USD Million)
Table 110. Europe Viral Vector and Plasmid DNA Revenue by Application (2023-2028) & (USD Million)
Table 111. Europe Viral Vector and Plasmid DNA Revenue by Country (2017-2022) & (USD Million)
Table 112. Europe Viral Vector and Plasmid DNA Revenue by Country (2023-2028) & (USD Million)
Table 113. Asia-Pacific Viral Vector and Plasmid DNA Revenue by Type (2017-2022) & (USD Million)
Table 114. Asia-Pacific Viral Vector and Plasmid DNA Revenue by Type (2023-2028) & (USD Million)
Table 115. Asia-Pacific Viral Vector and Plasmid DNA Revenue by Application (2017-2022) & (USD Million)
Table 116. Asia-Pacific Viral Vector and Plasmid DNA Revenue by Application (2023-2028) & (USD Million)
Table 117. Asia-Pacific Viral Vector and Plasmid DNA Revenue by Region (2017-2022) & (USD Million)
Table 118. Asia-Pacific Viral Vector and Plasmid DNA Revenue by Region (2023-2028) & (USD Million)
Table 119. South America Viral Vector and Plasmid DNA Revenue by Type (2017-2022) & (USD Million)
Table 120. South America Viral Vector and Plasmid DNA Revenue by Type (2023-2028) & (USD Million)
Table 121. South America Viral Vector and Plasmid DNA Revenue by Application (2017-2022) & (USD Million)
Table 122. South America Viral Vector and Plasmid DNA Revenue by Application (2023-2028) & (USD Million)
Table 123. South America Viral Vector and Plasmid DNA Revenue by Country (2017-2022) & (USD Million)
Table 124. South America Viral Vector and Plasmid DNA Revenue by Country (2023-2028) & (USD Million)
Table 125. Middle East & Africa Viral Vector and Plasmid DNA Revenue by Type (2017-2022) & (USD Million)
Table 126. Middle East & Africa Viral Vector and Plasmid DNA Revenue by Type (2023-2028) & (USD Million)
Table 127. Middle East & Africa Viral Vector and Plasmid DNA Revenue by Application (2017-2022) & (USD Million)
Table 128. Middle East & Africa Viral Vector and Plasmid DNA Revenue by Application (2023-2028) & (USD Million)
Table 129. Middle East & Africa Viral Vector and Plasmid DNA Revenue by Country (2017-2022) & (USD Million)
Table 130. Middle East & Africa Viral Vector and Plasmid DNA Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Viral Vector and Plasmid DNA Picture
Figure 2. Global Viral Vector and Plasmid DNA Revenue Market Share by Type in 2021
Figure 3. Plasmid DNA
Figure 4. Viral Vector
Figure 5. Viral Vector and Plasmid DNA Revenue Market Share by Application in 2021
Figure 6. Cancer Picture
Figure 7. Virus Infection Picture
Figure 8. Hereditary Disease Picture
Figure 9. Global Viral Vector and Plasmid DNA Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 10. Global Viral Vector and Plasmid DNA Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Viral Vector and Plasmid DNA Revenue Market Share by Region (2017-2028)
Figure 12. Global Viral Vector and Plasmid DNA Revenue Market Share by Region in 2021
Figure 13. North America Viral Vector and Plasmid DNA Revenue (USD Million) and Growth Rate (2017-2028)
Figure 14. Europe Viral Vector and Plasmid DNA Revenue (USD Million) and Growth Rate (2017-2028)
Figure 15. Asia-Pacific Viral Vector and Plasmid DNA Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. South America Viral Vector and Plasmid DNA Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Middle East and Africa Viral Vector and Plasmid DNA Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Viral Vector and Plasmid DNA Market Drivers
Figure 19. Viral Vector and Plasmid DNA Market Restraints
Figure 20. Viral Vector and Plasmid DNA Market Trends
Figure 21. Brammer Bio Recent Developments and Future Plans
Figure 22. Oxford BioMedica Recent Developments and Future Plans
Figure 23. Cobra Biologics Recent Developments and Future Plans
Figure 24. FinVector Recent Developments and Future Plans
Figure 25. Lonza Recent Developments and Future Plans
Figure 26. BioReliance Recent Developments and Future Plans
Figure 27. MolMed Recent Developments and Future Plans
Figure 28. FUJIFILM Diosynth Biotechnologies Recent Developments and Future Plans
Figure 29. UniQure Recent Developments and Future Plans
Figure 30. Aldevron Recent Developments and Future Plans
Figure 31. Richter-Helm Recent Developments and Future Plans
Figure 32. Eurogentec Recent Developments and Future Plans
Figure 33. OBiO Technology Recent Developments and Future Plans
Figure 34. Yposkesi Recent Developments and Future Plans
Figure 35. Cell and Gene Therapy Catapult Recent Developments and Future Plans
Figure 36. MassBiologics Recent Developments and Future Plans
Figure 37. Biovian Recent Developments and Future Plans
Figure 38. VGXI Recent Developments and Future Plans
Figure 39. Gene Synthesis Recent Developments and Future Plans
Figure 40. PlasmidFactory Recent Developments and Future Plans
Figure 41. Jikai Gene Recent Developments and Future Plans
Figure 42. Global Viral Vector and Plasmid DNA Revenue Share by Players in 2021
Figure 43. Viral Vector and Plasmid DNA Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 44. Global Top 3 Players Viral Vector and Plasmid DNA Revenue Market Share in 2021
Figure 45. Global Top 10 Players Viral Vector and Plasmid DNA Revenue Market Share in 2021
Figure 46. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 47. Global Viral Vector and Plasmid DNA Revenue Share by Type in 2021
Figure 48. Global Viral Vector and Plasmid DNA Market Share Forecast by Type (2023-2028)
Figure 49. Global Viral Vector and Plasmid DNA Revenue Share by Application in 2021
Figure 50. Global Viral Vector and Plasmid DNA Market Share Forecast by Application (2023-2028)
Figure 51. North America Viral Vector and Plasmid DNA Sales Market Share by Type (2017-2028)
Figure 52. North America Viral Vector and Plasmid DNA Sales Market Share by Application (2017-2028)
Figure 53. North America Viral Vector and Plasmid DNA Revenue Market Share by Country (2017-2028)
Figure 54. United States Viral Vector and Plasmid DNA Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Canada Viral Vector and Plasmid DNA Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Mexico Viral Vector and Plasmid DNA Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Europe Viral Vector and Plasmid DNA Sales Market Share by Type (2017-2028)
Figure 58. Europe Viral Vector and Plasmid DNA Sales Market Share by Application (2017-2028)
Figure 59. Europe Viral Vector and Plasmid DNA Revenue Market Share by Country (2017-2028)
Figure 60. Germany Viral Vector and Plasmid DNA Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. France Viral Vector and Plasmid DNA Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. United Kingdom Viral Vector and Plasmid DNA Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Russia Viral Vector and Plasmid DNA Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Italy Viral Vector and Plasmid DNA Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Asia-Pacific Viral Vector and Plasmid DNA Sales Market Share by Type (2017-2028)
Figure 66. Asia-Pacific Viral Vector and Plasmid DNA Sales Market Share by Application (2017-2028)
Figure 67. Asia-Pacific Viral Vector and Plasmid DNA Revenue Market Share by Region (2017-2028)
Figure 68. China Viral Vector and Plasmid DNA Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Japan Viral Vector and Plasmid DNA Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. South Korea Viral Vector and Plasmid DNA Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. India Viral Vector and Plasmid DNA Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Southeast Asia Viral Vector and Plasmid DNA Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Australia Viral Vector and Plasmid DNA Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. South America Viral Vector and Plasmid DNA Sales Market Share by Type (2017-2028)
Figure 75. South America Viral Vector and Plasmid DNA Sales Market Share by Application (2017-2028)
Figure 76. South America Viral Vector and Plasmid DNA Revenue Market Share by Country (2017-2028)
Figure 77. Brazil Viral Vector and Plasmid DNA Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Argentina Viral Vector and Plasmid DNA Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Middle East and Africa Viral Vector and Plasmid DNA Sales Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Viral Vector and Plasmid DNA Sales Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Viral Vector and Plasmid DNA Revenue Market Share by Country (2017-2028)
Figure 82. Turkey Viral Vector and Plasmid DNA Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 83. Saudi Arabia Viral Vector and Plasmid DNA Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 84. UAE Viral Vector and Plasmid DNA Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 85. Methodology
Figure 86. Research Process and Data Source